Completed OBSERVATIONAL NCT03628300

Neurotoxicity Evaluation of Beta-lactams in Intensive Care Unit and Identification of the Risk Factors (NebuLar)

Sponsor: Centre Hospitalier Universitaire, Amiens

Conditions Acute Kidney Injury Beta Lactams Critical Care Neurotoxicity Sepsis Therapeutic Drug Monitoring

Updated 5 times since 2018 Last updated: Nov 24, 2022 Started: Jan 1, 2017 Primary completion: Jul 1, 2017 Completion: Jul 1, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Acute Kidney Injury and Beta Lactams, this trial is completed. The trial is conducted by Centre Hospitalier Universitaire, Amiens and has accumulated 5 data snapshots since 2017. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Dec 2022 — Jul 2024 [monthly]

Completed
Jan 2021 — Dec 2022 [monthly]

Completed
Sep 2018 — Jan 2021 [monthly]

Completed

First recorded

Jan 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Centre Hospitalier Universitaire, Amiens

Data source: Centre Hospitalier Universitaire, Amiens

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.